RESORCE Trial: Role of Regorafenib in Unresectable HCC Treatment - 101341

Spotlight
Video

RESORCE Trial: Role of Regorafenib in Unresectable HCC Treatment

obr has 300 videos Subscribe Here

Loading........
Description: Alan P. Venook, MD, FASCO of Helen Diller Family Comprehensive Cancer Center discusses the date of the RESORCE Trial and how it changed the role of regorafenib in the treatment of unresectable HCC at the 2017 Gastrointestinal Cancers Symposium (ASCO GI) in San Francisco, CA.
Shared By : obr
Posted on : 01/25/17
Added : 1 year ago